Nursery Screening for Ganoderma Response in Oil Palm Seedlings: A Manual (Techniques in Plantation Science)
Description:
This is a hands-on, practical guide covering seedling screening for disease response in oil palm for pathology, breeding and genetics. Oil palm is the top oil crop in the world and Ganoderma is the most devastating disease of oil palm. The authors are all actively engaged in oil palm seed production and breeding and bring together the many aspects of seedling disease testing in to one integrated manual.
Presenting sound practices based on scientific innovation and knowledge, this guide provides techniques integrated with expertise and also looks towards future possibilities. Promoting green, eco-friendly agriculture, this book covers: health and safety considerations; media preparation for in vitro culture; collecting isolates and culture preparation; preparation of Ganoderma inoculum; nursery inoculation; and scoring response.
Based on experience and protocols, this is an invaluable manual for students and researchers in agriculture, plant breeders, growers, traders and production companies interested in the practicalities of oil palm pathology.
Best prices to buy, sell, or rent ISBN 9781786396242
Frequently Asked Questions about Nursery Screening for Ganoderma Response in Oil Palm Seedlings: A Manual (Techniques in Plantation Science)
The price for the book starts from $29.89 on Amazon and is available from 18 sellers at the moment.
If you’re interested in selling back the Nursery Screening for Ganoderma Response in Oil Palm Seedlings: A Manual (Techniques in Plantation Science) book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Nursery Screening for Ganoderma Response in Oil Palm Seedlings: A Manual (Techniques in Plantation Science) book, the best buyback offer comes from and is $ for the book in good condition.
Not enough insights yet.
Not enough insights yet.